Rheumatoid Arthritis Research and Therapies
Rheumatoid Arthritis Research and Therapies is a research topic within Rheumatology. Science Explorer counts 54k research works in it since 1950. 20.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathogenesis, classification, management, and treatment outcomes of rheumatoid arthritis. It covers topics such as the role of inflammation, biological and disease-modifying therapies, autoantibodies, joint inflammation, cytokines, cardiovascular risk, synoviocytes, and the genetic contribution to the disease.
- Rheumatoid Arthritis
- Inflammation
- Biological Therapy
- Disease-Modifying Antirheumatic Drugs
- Autoantibodies
- Joint Inflammation
- Cytokines
- Cardiovascular Risk
- Synoviocytes
- Genetic Contribution
- Research works
- 54k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 20.3% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +13% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Rheumatoid Arthritis Research and Therapies research?
By volume, China and the United States publish the most (1.6k and 1.4k works in 2022–2025).
By volume, 2022–2025
- 1 China 1.6k works
- 2 United States 1.4k works
- 3 United Kingdom 705 works
- 4 Japan 462 works
- 5 India 436 works
- 6 France 417 works
- 7 Italy 406 works
- 8 Germany 382 works
- 9 Spain 382 works
- 10 Netherlands 309 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Rheumatoid Arthritis Research and Therapies research?
By volume in 2022–2025, Leiden University Medical Center publishes the most Rheumatoid Arthritis Research and Therapies research, followed by Charité - Universitätsmedizin Berlin and Association of Rheumatologists of Russia.
By volume, 2022–2025
- 1 Leiden University Medical CenterNetherlands 51 works
- 2 Charité - Universitätsmedizin BerlinGermany 39 works
- 3 Association of Rheumatologists of RussiaRussia 39 works
- 4 InsermFrance 37 works
- 5 Brigham and Women's HospitalUnited States 35 works
- 6 Karolinska InstitutetSweden 32 works
- 7 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 32 works
- 8 Peking UniversityChina 32 works
- 9 Harvard UniversityUnited States 32 works
- 10 Anhui University of Traditional Chinese MedicineChina 32 works
Who are the leading researchers in Rheumatoid Arthritis Research and Therapies?
The most-cited researchers publishing on Rheumatoid Arthritis Research and Therapies include Vivian Welch and Cyrus Cooper.
- 1 Vivian Welch Canada 14k citations
- 2 Cyrus Cooper United Kingdom 7.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Rheumatoid Arthritis Research and Therapies research done?
The largest centres of Rheumatoid Arthritis Research and Therapies research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in La Marsa.
Largest cities, 2022–2025
Where it is the local speciality
- La MarsaTN · 22.8 works79×
Location quotient: how much more of its research is in Rheumatoid Arthritis Research and Therapies than the world average.
Where is the best place to study Rheumatoid Arthritis Research and Therapies?
Among universities, judged by research, Zhejiang Chinese Medical University, University of Occupational and Environmental Health Japan and Anhui Medical University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | Zhejiang Chinese Medical UniversityChina | 65.5 | 43.3% | 8.4× | 22 | +33.5% |
| 2 | University of Occupational and Environmental Health JapanJapan | 65.5 | 42.8% | 30.3× | 18 | -14.3% |
| 3 | Anhui Medical UniversityChina | 64.6 | 36.9% | 9.2× | 27 | +3.4% |
| 4 | Anhui University of Traditional Chinese MedicineChina | 62.1 | 32.4% | 33.3× | 32 | -39.3% |
| 5 | Shanxi Medical UniversityChina | 61.9 | 25.1% | 8.4× | 18 | +236.5% |
| 6 | Karolinska InstitutetSweden | 61.3 | 25.8% | 7.2× | 32 | +14.2% |
| 7 | Chengdu University of Traditional Chinese MedicineChina | 57.2 | 42.2% | 6.7× | 15 | — |
| 8 | Beijing University of Chinese MedicineChina | 55.1 | 28.6% | 7.7× | 14 | +131.1% |
| 9 | University of IoanninaGreece | 55.1 | 44.9% | 7.0× | 11 | -18.0% |
| 10 | Guangzhou University of Chinese MedicineChina | 54.9 | 28.6% | 9.4× | 18 | +4.2% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Rheumatoid Arthritis Research and Therapies research growing?
Output in 2018–2022 was 13% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Rheumatoid Arthritis Research and Therapies.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.